Real-World Outcomes of Dabrafenib Plus Trametinib in Patients with Iodine-Refractory/Radioactive Iodine-Refractory Thyroid Carcinoma: A Single-Center Experience in Quality of Life and Treatment Efficacy

Tafinlar (dabrafenib) - Novartis

Mekinist (trametinib) - Novartis, BeOne Medicines

Jianhong Yu 1; Shuping Wu 2; Chang Liu 2; Hui Liu 2; Yu Wu 2

Sep 9, 2026